Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Wichmann

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2021
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
The Journal of Infection|February 16, 2023
Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020Teresa M Nygren, Antonia Pilic, Merle M Böhmer, et al.
Journal of Travel Medicine|May 23, 2008
Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and ThailandGwendolin Ropers, Mirna Du Ry van Beest Holle, Ole Wichmann, et al.
The Journal of Infection|February 5, 2024
Corrigendum to "Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020" [J Infect 86 (2023) 369-375]Teresa M Nygren, Antonia Pilic, Merle M Böhmer, et al.
The Lancet Regional Health. Europe|September 24, 2021
Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)Nicole Friedrich, Christina Poethko-Müller, Ronny Kuhnert, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2021
Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infectionThomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 6, 2016
Cornelius Remschmidt, Thomas Harder, Ole Wichmann, et al.
Vaccine|February 25, 2014
Cost-effectiveness of childhood rotavirus vaccination in GermanyPamela Aidelsburger, Kristin Grabein, Katharina Böhm, et al.
The Journal of Infection|July 12, 2024
Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic reviewMatas Griskaitis, Iris Thielemann, Viktoria Schönfeld, et al.
Bulletin of the World Health Organization|March 11, 2009
Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigationOle Wichmann, Anette Siedler, Daniel Sagebiel, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 16, 2021
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021Thomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
The Journal of Infection|February 16, 2023
Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020Teresa M Nygren, Antonia Pilic, Merle M Böhmer, et al.
Journal of Travel Medicine|May 23, 2008
Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and ThailandGwendolin Ropers, Mirna Du Ry van Beest Holle, Ole Wichmann, et al.
The Journal of Infection|February 5, 2024
Corrigendum to "Tick-borne encephalitis: Acute clinical manifestations and severity in 581 cases from Germany, 2018-2020" [J Infect 86 (2023) 369-375]Teresa M Nygren, Antonia Pilic, Merle M Böhmer, et al.
The Lancet Regional Health. Europe|September 24, 2021
Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)Nicole Friedrich, Christina Poethko-Müller, Ronny Kuhnert, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2021
Authors' response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infectionThomas Harder, Judith Koch, Sabine Vygen-Bonnet, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|November 6, 2016
Cornelius Remschmidt, Thomas Harder, Ole Wichmann, et al.
Vaccine|February 25, 2014
Cost-effectiveness of childhood rotavirus vaccination in GermanyPamela Aidelsburger, Kristin Grabein, Katharina Böhm, et al.
The Journal of Infection|July 12, 2024
Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic reviewMatas Griskaitis, Iris Thielemann, Viktoria Schönfeld, et al.
Bulletin of the World Health Organization|March 11, 2009
Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigationOle Wichmann, Anette Siedler, Daniel Sagebiel, et al.
Pageof 18